Catalyst Wire Dossier Catalyst Wire Dossier

Combination antihypertensive drug (ARB non-responder regimen)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Combination antihypertensive drug (ARB non-responder regimen), covering 2015-11-10 to 2015-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM [Phase 4]

See pricing